| metabolites |
retention time |
P valuea |
A(non-invasive cancers) |
B(invasive/metastasic cancers) |
Rb |
| glycerol |
12.373 |
0.045 |
0.0119 ± 0.0052 |
0.0071 ± 0.0049 |
-0.40 |
| butanedioic acid |
13.801 |
0.027 |
0.0005 ± 0.0001 |
0.0003 ± 0.0001 |
-0.40 |
| L-serine |
15.134 |
0.003 |
0.0009 ± 0.0002 |
0.0005 ± 0.0003 |
-0.44 |
| L-threonine |
15.938 |
0.005 |
0.0010 ± 0.0002 |
0.0004 ± 0.0004 |
-0.60 |
| L-proline |
20.391 |
0.082 |
0.0041 ± 0.0013 |
0.0029 ± 0.0011 |
-0.29 |
| myo-inositol |
35.389 |
0.027 |
0.0029 ± 0.0006 |
0.0039 ± 0.0011 |
0.34 |
|
| aP values were calculated based on Mann-Whitney test (significance at P<0.05). bR value was calculated from the arithmetic mean values of each group. R=(B-A)/A. R
with a positive value indicates a relatively higher concentration present in invasive/metastasic cancers while a negative value means a relatively lower concentration as
compared to the non-invasive cancers. |
| Table 3b: List of different metabolites identified in non-invasive and invasive/metastatic gastric cancer patients. |
